Anoctamin 1 is Apically Expressed on Thyroid Follicular Cells and Contributes to ATP-and Calcium-Activated Iodide Efflux

Introduction
The thyroid gland accumulates iodide for the synthesis of thyroid hormones. Circulating iodide is actively concentrated in thyroid follicular cells by the Sodium Iodide Symporter (NIS) or SLC5A5, a cotransporter located on the basolateral membrane that uses the inward Na + gradient generated by the Na + -K + ATPase to drive iodide uptake against its electrochemical gradient [1] . Intracellular iodide then passively diffuses across the apical membrane into the follicular lumen where it is incorporated into thyroglobulin in a reaction catalyzed by thyroid peroxidase. Whereas there is a consensus that basolateral iodide uptake is uniquely mediated by NIS, multiple anion channels and/or transporters are thought to contribute to the delivery of intracellular iodide to the follicular lumen. These pathways may be differentially regulated according to the physiological needs for thyroid hormone synthesis. Indeed, radioiodide efflux from thyroid cells has been shown to be stimulated by G proteincoupled receptors activating distinct signaling pathways, including calcium-, PKC-, PLA 2 -, and cAMP-dependent mechanisms [2] [3] [4] [5] [6] [7] [8] [9] .
The pathways mediating apical iodide efflux from thyroid cells are still largely unknown. The major candidate is pendrin or SLC26A4, first identified as the protein mutated in Pendred syndrome, an inherited disorder associated with deafness, goiter and impaired iodide organification [10] . Pendrin is located on the apical membrane of thyroid follicular cells, supports Cl -/I -exchange, and mediates iodide efflux from polarized cells with heterologous expression of NIS and pendrin [11] [12] [13] . However, pendrin-knockout mice are euthyroid, and not all subjects bearing homozygous loss-of-function mutations manifest thyroid dysfunction, suggesting redundancy in the role of pendrin in the thyroid gland [14, 15] .
Thyrocytes express several chloride channels known to be permeable to iodide, and it has been proposed that such channels may also contribute to iodide efflux. The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in the thyroid gland [16] and subclinical hypothyroidism has been reported in cystic fibrosis patients [17] . CFTR is active as a regulated apical chloride conductance in the pig thyroid [18] , but its role in iodide fluxes has not yet been investigated. Nevertheless, several models have been proposed by which CFTR may modulate thyroid iodide fluxes. Thus, CFTR may directly transport iodide, may supply chloride as the counterion for pendrin-dependent Cl -/I -exchange, or may alter sodium fluxes and by consequence NIS-mediated iodide uptake [18] .
The voltage-gated ClC-5 chloride channel is highly expressed in the thyroid gland of mice and is localized to the apical pole of thyrocytes [19] . CLC-5 knockout mice develop euthyroid goiter and have delayed iodide organification compatible with impaired delivery of iodide to the follicular lumen [19] . However, pendrin expression is also reduced in CLC-5 deficient mice, suggesting that delayed iodide efflux may be secondary to pendrin downregulation [19] .
Anoctamin 1 (ANO1, TMEM16A) is a calcium-activated chloride channel (CaCC) with a role in transepithelial electrolyte transport, nociception, and smooth muscle contractility [20] [21] [22] [23] . It belongs to a widely-distributed anoctamin family of 10 paralogs (ANO1-10; TMEM16A-K) sharing a common transmembrane topology, but differing in function, which for many anoctamins is still unknown [23, 24] . ANO1 mRNA is present in the thyroid gland [25] [26] [27] , and CaCC currents have been recorded in thyroid follicular cells, where they have been proposed to play a role in regulating in chloride and iodide homeostasis [27, 28] . ANO1 has a higher permeability for iodide than for chloride [21, 22] raising the possibility that thyroidal ANO1 may function as a calcium-activated iodide channel contributing to the delivery of iodide to the follicular lumen. Several agents have been reported to stimulate calcium-dependent radioiodide efflux from cultured thyrocytes [2] [3] [4] [5] 8] , however, the channel or transporter mediating this response has yet to be elucidated. This study was designed to examine the expression and localization of ANO1 in the thyroid gland, and test the hypothesis that ANO1 mediates calcium-activated iodide efflux from thyroid follicular cells.
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Materials and Methods
Immunohistochemistry
Excess non-neoplastic thyroid tissue was obtained, after histologic review, from the Anatomic Pathology archives of the Bellaria Hospital (Bologna, Italy). Formalin-fixed tissue sections were dewaxed, rehydrated, and subjected to antigen retrieval (Tris-EDTA pH 9.0, 98°C, 20 min). Endogenous peroxidase activity was blocked with methanol (0.5%, 20 min). Sections were incubated overnight with rabbit monoclonal antibody against ANO1 (clone SP31, Spring Bioscience, Pleasanton, CA, USA) [29] , and processed with the Novolink Polymer detection system (Novocastra, UK) according to the manufacturer's instructions. Negative control tissue sections were processed in parallel by omitting the primary antibody.
Cell culture, cDNA transfection and siRNA treatment FRTL-5 rat thyroid follicular cells were cultured in Coon's Modified F12 medium supplemented with 5% newborn calf serum, 1 µg/ml insulin, 3.6 ng/ml hydrocortisone, 5 µg/ml apotransferrin, 10 ng/ml glycyl-L-histidyl-L-lysine acetate, 10 ng/ml somatostatin and 1 mU/ml TSH, 100 U/ml penicillin, and 100 µg/ml streptomycin [30] . A cell line with stable expression of the iodide-sensitive yellow fluorescent protein YFP-H148Q/I152L (FRTL-5/YFP) was used to monitor iodide fluxes [31] . ANO1 gene silencing in FRTL-5/ YFP cells was carried out with siRNA directed against rat ANO1. Pre-designed Mission siRNA (100 nM) against rat ANO1 (RefSeq ID NM_001107564) or a scrambled negative control were transfected using N-TER nanoparticles according to manufacturer's instructions (Sigma-Aldrich). Cells were used 48-72 h later for mRNA analysis or measurement of iodide fluxes.
CHO (Chinese hamster ovary) cells were cultured in F12 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin. A CHO cell line with stable expression of YFP-H148Q/I152L and NIS (designated CHO/YFP/NIS) was established by transfection with Lipofectamine 2000 (Life Technologies Italia, Monza, Italy) and selection with appropriate antibiotics. First, CHO cells were transfected with a pcDNA3-Neo vector containing the YFP-H148Q/I152L coding sequence and cultured in the presence of 400 µg/ml geneticin. Cell lines with persistent and uniform fluorescence were then transfected with pcDNA3.1/Zeo containing the full length human NIS cDNA (S. Jhiang, Ohio State University), and selected with 250 µg/ml zeocin. Cell lines were screened for NIS-mediated iodide uptake using the YFPbased fluorescence assay, as previously described [31] . ANO1 was transiently expressed in CHO/YFP/NIS cells by transfection with pcDNA 3.1 containing cDNA for human ANO1 abc isoform (LJV Galietta, Genova, Italy) using Lipofectamine. Mock transfection with empty vector was used as a negative control. 48-72 h later cells were used for mRNA analysis or iodide flux measurement. [32] or designed using Primer-BLAST, and are available on request. When rat sequences were not available in Refseq, primers were designed against mouse or predicted rat transcripts. Target gene expression was normalized against β-actin as a reference gene, and expressed as 2 -∆∆Ct . The amplification efficiency of target and reference genes was equal and close to 1.
YFP-based iodide flux assay
Iodide fluxes were monitored as iodide-induced changes in fluorescence in cells expressing YFP-H148/ I152L, as described previously [31] . Cells were cultured on glass coverslips, mounted in a thermostatically- -free BSS was prepared by excluding calcium salts and adding 2 mM EGTA. Chloride-free BSS was prepared by substituting chloride salts with glutamate salts.
Fluorescence (excitation 500+12.5 nm, emission 545+17.5 nm) was monitored with an Axiovert 200 inverted microscope using a 40x objective (Carl Zeiss, Arese, Italy). Images were acquired for 50 ms every 2s with a Photometrics Coolsnap fx CCD camera (Crisel Instruments, Rome Italy). Fluorescence intensity was quantified with Universal Imaging Metafluor software (Crisel Instruments, Rome, Italy). Cellular fluorescence was monitored as the average intensity of a population of cells (typically 20-100), or of individual cells within a population, after subtraction of background fluorescence. In order to correct for fluorescence decay due to photobleaching, resting fluorescence of cells perfused with BSS was fit over time to a 1-phase exponential decay function, to obtain a best fit curve (F 0 ). Fluorescence at each time point (F) during the experiment was normalized to F 0 , and relative fluorescence (F/F 0 ) was expressed as a % value. Iodide influx was expressed as the maximal rate of fluorescence quenching (% s -1 ), determined by fitting F/ F 0 data to a 1-or 2-phase exponential decay curve and obtaining the derivative of the best-fit curve at the point of maximal slope. Iodide efflux was expressed as the maximal rate of fluorescence recovery (% s -1 ), where 0% recovery refers to the fluorescence of iodide-loaded cells, and 100% is the resting fluorescence of cells lacking iodide. ATP EC 50 and Hill coefficients were obtained by non-linear regression fitting of log concentration-response replicate data to a sigmoidal curve. Fluorescence data analysis and curve fitting was carried out with GraphPad Prism (GraphPad Software, La Jolla, CA, USA).
Statistical analysis
Statistical analysis was carried out with GraphPad Prism. Data are expressed as mean values+SEM of n values, where n represents the number of independent experiments, or when specifically indicated, the number of single cells analyzed. Comparisons between treatment groups were made by one-way ANOVA followed by Dunnett's or Bonferroni's multiple comparison test. Statistical significance was assumed for p<0.05.
Results
Anoctamin expression in thyroid tissue and cells
Immunohistochemistry of normal human thyroid tissue with an antibody against ANO1, routinely used to support a pathologic diagnosis of GIST [29] , revealed positive staining on follicular cells (Fig. 1A) . Staining was less intense than in GIST samples, despite the use of a more concentrated antibody (1:300 versus 1:400). Staining was always restricted to the apical membrane of thyrocytes, facing the lumen of thyroid follicles. Staining of follicles within the same tissue section was of variable intensity, but was more evident in follicles with columnar cells rather than low cuboidal cells, suggesting a greater expression of ANO1 in activated cells than in quiescent cells. No staining was seen in parafollicular C-cells. Staining was absent from thyroid and GIST tissue sections processed in parallel without primary antibody.
ANO1 mRNA was detected in human thyroid tissue (Fig. 1B) , as well as in rat FRTL-5 thyroid cells (Fig. 1C) . FRTL-5 cells also expressed mRNA for other anoctamins, specifically ANO6, ANO8 and ANO10 (Fig. 1C) . Cells cultured without TSH for 7 days retained ANO1 mRNA expression (Fig. 1D) ; in contrast, NIS mRNA was eliminated, consistent with the known dependence of NIS expression on TSH [1] .
Alternative splicing of ANO1 transcripts is known to produce several isoforms, some of which differ in their functional properties [25] . Isoforms lacking certain protein segments are generated by use of an alternative promoter (segment a), or skipping of exon 6b (segment b), exon 13 (segment c) and exon 15 (segment d). RT-PCR analysis of ANO1 splice variants in FRTL-5 cells showed that segments a and c are present in all transcripts whereas segment d is always skipped (Fig. 1E) . In contrast, dual bands corresponding to transcripts with and (Fig. 1E) . 
CaCC activity in FRTL-5 cells
To determine whether thyroid cells possess CaCC activity compatible with ANO1, anion fluxes were measured in FRTL-5/YFP cells cultured without TSH for 7-10 days in order to eliminate NIS-mediated iodide uptake. CaCC activity was measured by substituting 100 mM NaCl in the perfusate with equimolar KI in the presence of a stimulus that elevates intracellular calcium concentration [20] . Purinergic receptor stimulation is known to mobilize intracellular calcium in FRTL-5 cells [6, 33, 34] , and in other cell types activates ANO1 [20, 22] . The substitution of Na + with K + clamps the membrane potential close to zero and serves to maximize ANO1 activity by enhancing the intrinsic Ca 2+ -sensitivity of ANO1, and by preventing the hyperpolarization that may arise from Ca 2+ -dependent K + channels [20] . NaCl/KI substitution resulted in a slow quenching of FRTL-5/YFP fluorescence (20% 
) that was dramatically enhanced by both ATP and ionomycin (80% within 20s) ( Fig. 2 and 3A ). Fluorescence quenching induced by both stimuli was abolished by chelating intracellular and extracellular calcium (Ca
2+
-free medium + BAPTA) confirming the calcium-dependence of halide fluxes (Fig. 3A and 3B ). Removing only extracellular calcium had no effect, suggesting that halide fluxes are dependent on the mobilization of calcium from intracellular stores. Fluorescence quenching was enhanced by P2Y purinergic receptor agonists, with potencies of 0.95 µM for ATP (EC 50 =-6.02+0.06, n=9), 1.5 µM for UTP (EC 50 =-5.82+0.10, n=5) and 13 µM for ADP (EC 50 =-4.88+0.09, n=5) (Fig. 3C) . Hill coefficients for all three nucleotides were greater than 1 (2.1 for ATP, and 2.7 for both UTP and ADP) suggesting cooperativity. Substituting NaCl with equimolar NaI rather than KI decreased ATP's potency 10-fold to 11 µM (EC 50 =-4.98+0.25, n=4), and reduced the Hill coefficient to 0.8 (Fig. 3C) , consistent with the voltage dependence of CaCC activity. ATP-stimulated fluorescence quenching was inhibited by CaCC/ANO1 blockers including CaCCinh-A01 (10 (Fig. 3D ), but was unaffected by the respective vehicle(s). T16Ainh-A01 and niflumic acid on their own reduced resting fluorescence by up to 15%.
Calcium-activated iodide efflux from FRTL-5 cells
To determine whether CaCC/ANO1 contributes to iodide efflux from thyroid cells, FRTL-5/YFP cells expressing NIS were first loaded with iodide by exposing them to 100 µM NaI for 10 min, and were then stimulated with ATP or ionomycin to stimulate efflux. We have previously demonstrated that FRTL-5/YFP cells cultured in the presence of TSH, respond to 100 µM NaI with a perchlorate-sensitive decrease in YFP fluorescence due to NIS-mediated iodide uptake [31] . Rinsing iodide-loaded cells with iodide-free BSS results in a slow recovery of resting fluorescence due to iodide efflux, complete within 15-20 min (Fig. 4A) . In contrast, rinsing cells with iodide-free BSS containing 100 µM ATP or 1 µM ionomycin causes fluorescence to return to resting levels within 30 seconds suggesting that these agents induce a rapid and complete loss of measurable intracellular iodide (Fig. 4A) . Stimulation of cells with ATP or ionomycin in the continued presence of extracellular iodide causes a short-lived fluorescence recovery (Fig. 4A) , suggesting that activation of iodide efflux by ATP and ionomycin is transient, and that iodide is subsequently re-accumulated by cells via NIS. Both ATP and ionomycin cause small (10-15%) transient increases in resting fluorescence. ATP-and ionomycin-induced fluorescence recovery was abolished by chelating intracellular and extracellular calcium, but was unchanged by removing only extracellular calcium, demonstrating the dependence of iodide efflux on the mobilization of calcium from intracellular stores (Fig. 4B and 4C ). ATP-stimulated fluorescence recovery was independent of extracellular chloride (Fig. 4D ), but was inhibited by CaCC/ANO1 blockers including CaCCinh-A01 (10 µM), T16Ainh-A01 (30 µM), niflumic acid (30 µM) and tannic acid (30 µM) (Fig. 5) .
The role of ANO1 in ATP-induced iodide efflux in thyroid cells was assessed by silencing ANO1 expression in FRTL-5/YFP cells with three different siRNAs directed against rat ANO1 (rANO1 siRNA-1, -2 and -3). Knockdown efficiency was assessed by RT-PCR, and found to be approximately 50% compared to a scrambled siRNA negative control (p<0.01, one-way ANOVA) (Fig. 6A) . ATP-stimulated fluorescence recovery was significantly reduced in cells treated with each of the three rANO1 siRNAs compared to cells treated with scrambled siRNA (p<0.001, one-way ANOVA) (Fig. 6B) . Examination of fluorescence changes in individual cells following rANO1 siRNA treatment revealed a mixed population of cells with either slow or rapid fluorescence recovery in response to ATP, despite comparable levels of iodide-induced quenching (Fig. 6C) , suggesting an all-or-none silencing of calcium-activated iodide efflux in a small number of individual cells within the population. 
Iodide efflux from NIS-and ANO1-expressing CHO cells
To confirm that ANO1 is capable of mediating calcium-activated iodide efflux, human ANO1 was transiently expressed in a CHO cell line with stable expression of NIS and YFP (CHO/YFP/NIS). RT-PCR analysis confirmed the presence of ANO1 mRNA in CHO/YFP/NIS cells transfected with ANO1 cDNA, but not in cells transfected with empty vector (mock) or in untreated cells (control) (Fig. 7A) . CHO/YFP/NIS cells respond to iodide (100 µM NaI) with a reversible decrease in fluorescence consistent with NIS-mediated uptake, similar, though smaller in magnitude, to that of FRTL-5/YFP cells (Fig. 7B) . Iodide-induced fluorescence quenching was similar in cells transfected with ANO1 or empty vector, suggesting that iodide uptake is not affected by ANO1 expression. In CHO/YFP/NIS cells, fluorescence recovery in iodide-free buffer occurred slowly over a 15 min period (Fig. 7B) , and was not stimulated by ionomycin (Fig. 7C) confirming that CHO cells do not have endogenous calcium-activated fluxes detectable with the YFP assay. Ionomycin actually provoked a further decrease in cellular fluorescence; however, a similar effect was seen on resting fluorescence in the absence of iodide (Fig. 7B) suggesting that it is independent of iodide transport. Addition of ionomycin to ANO-1 transfected CHO/YFP/NIS cells revealed two distinct populations: 16% of cells (79/488 cells from 19 independent transfections) exhibited a rapid but partial recovery of resting fluorescence consistent with calcium-stimulated iodide efflux; 84% cells (409/488 cells) showed a small decrease similar to that seen in cells lacking ANO1 (Fig. 7D) , suggesting that ANO1 may be functional in only a fraction of cells, possibly due to low transfection efficiency or poor membrane targeting in these cells. Ionomycin-induced fluorescence recovery in CHO cells expressing ANO1 was smaller that seen in FRTL-5 cells, however, it was probably underestimated because of the opposing effect of ionomycin on resting fluorescence.
Discussion
The results of the present study support the hypothesis that ANO1 contributes to iodide fluxes in the thyroid gland. In human tissues, ANO1 protein was restricted to the apical membrane of follicular cells, and is therefore ideally located to mediate ion exchange between the cellular and follicular compartments. ANO1 was not uniformly detected in all follicles, but was more evident in those with columnar cells rather than low cuboidal cells, suggesting that its expression may be regulated according to the functional status of follicles. A similar pattern has been described for pendrin, and is in line with the well-known functional and morphological heterogeneity between follicles that characterizes the thyroid gland [35] . TSH does not appear to be essential for ANO1 gene transcription in FRTL-5 cells, but it remains to be determined whether TSH may exert a modulatory effect on ANO1 expression at a transcriptional or post-transcriptional level.
CaCC activity has previously been identified in thyroid cells. Patch-clamp studies have revealed Ca 2+ -activated Cl -currents in FRTL-5 cells that are stimulated by ATP, and by calcium influx through transient receptor potential channels (TRPCs) [27, 28] . Using the YFP-based assay, we detected CaCC activity in FRTL-5 cells compatible with ANO1 function. CaCC activity was stimulated by purinergic receptor agonists through mobilization of Ca 2+ from intracellular stores. In nociceptive sensory neurons, ANO1 is present in plasma membrane lipid rafts in close apposition to the endoplasmic reticulum, and is preferentially activated by localized rather than by global changes in intracellular calcium concentration. [36] . Depolarization increased the potency of ATP in FRTL-5 cells. This is unlikely to reflect increased calcium mobilization, since depolarization has been shown not to change ATPinduced Ca 2+ release from intracellular stores in these cells [37] . A more likely explanation lies in the voltage-dependence of ANO1 which manifests an increased calcium-sensitivity as the membrane potential is shifted from negative to positive values [22, 25] . Hill coefficients for purinergic agonists in a depolarizing medium were >1 suggesting cooperativity. The calciumsensitivity of ANO1 is also characterized by cooperativity, possibly due to calcium binding at multiple sites. The mechanism by which calcium activates and modulates ANO1 appear to be complex, involving calmodulin as well as direct binding to ANO1 [23] . ANO1 splice variants differ in their calcium-sensitivity, the (ac) isoform having a significantly higher Ca 2+ sensitivity than the (abc) isoform [25] . Both (ac) and (abc) isoforms are present in FRTL-5 cells, but the significance is unclear. ATP-stimulated fluorescence quenching in FRTL-5 cells was inhibited by known ANO1/CaCC blockers, most notably by CaCCinh-A01, and to a lesser degree by T16Ainh-A01, niflumic acid and tannic acid, albeit at high concentrations. All four compounds inhibit calcium-activated chloride currents in cells with heterologous and endogenous ANO1 expression [21, 22, [38] [39] [40] [41] , although niflumic acid and tannic acid are not selective. The pharmacological sensitivity of ANO1 may vary according to cell type and the ionic environment of the channel. The inhibition of ANO1 by niflumic acid, for instance, is antagonized by the occupancy of anions in the pore, and is less effective in the presence of iodide versus chloride [41] . The apical localization of ANO1 on thyroid follicular cells and its higher permeability for iodide than for chloride raises the possibility that ANO1 may mediate calcium-activated iodide efflux from thyroid cells. Indeed, ATP and ionomycin induced a rapid and complete loss of iodide from pre-loaded FRTL-5 cells, secondary to calcium release from intracellular stores. ATP and calcium ionophores have previously been shown to stimulate radioiodide efflux from FRTL-5 cells [4] [5] [6] 8] , although in one study the effect of ATP was reported to be independent of calcium mobilization [8] . In the present study, calcium-activated iodide efflux was rapid and transient, allowing iodide to be subsequently re-accumulated via NIS. This may reflect the transient nature of calcium mobilization or may be due to inactivation of the iodide-permeable channel. ANO1 currents are also transient, and following opening, ANO1 channels are inactivated in the continued presence of elevated calcium, possibly via calmodulin-dependent kinase [42] . ANO1/CaCC blockers also inhibited calcium-activated iodide efflux from FRTL-5 cells, CaCCinh-A01 showing the greatest effect. Notably, niflumic acid and tannic acid were more effective against iodide efflux than influx. In the case of niflumic acid this could be explained by the reduced anion occupancy of the ANO1 pore in the presence of the lower concentration of iodide used in efflux studies. However, niflumic acid and tannic acid are known to have a broad spectrum of activity, and may therefore inhibit additional pathways of iodide efflux. ATP-induced iodide efflux from FRTL-5 cells was also inhibited by three ANO1-specific siRNAs, however, knockdown of ANO1 gene expression was only partial, and we cannot exclude the involvement of other calcium-sensitive pathways in addition to ANO1.
The present study has technical drawbacks. The first lies in the high concentration of extracellular iodide (100 µM) used to load cells for the measurement of iodide efflux. This concentration is considerably higher than the circulating iodide concentration in the human body (<1 µM), and was necessary both to stimulate uptake by NIS (whose affinity for iodide is ~30 µM) and to be detectable by YFP-H148Q/Y152L (whose affinity for iodide is ~2 mM). Although measurement of iodide fluxes with radiotracers can be achieved with lower external iodide concentrations (typically 10 µM), the rapid and transient nature of ANO1 activation would be poorly detected with radioiodide. The second drawback lies in the use of FRTL-5 cells which, although highly functional, are not polarized and do not support the vectorial transport that occurs in the intact thyroid gland in vivo. The ability of ANO1 to mediate calcium-dependent iodide efflux was confirmed in CHO cells with heterologous expression of NIS and ANO1, however, further studies with polarized thyroid cells will be necessary to confirm apical iodide efflux by ANO1.
Could other anoctamins contribute to calcium-activated iodide fluxes in thyroid cells? In addition to ANO1, FRTL-5 thyrocytes express mRNA for ANO6 (TMEM16F), ANO8 (TMEM16H), and ANO10 (TMEM16K), confirming and extending Viitanen et al.'s finding of ANO1 and ANO10 in these cells [27] . ANO6 contributes to calcium-dependent phospholipid scrambling in platelets and is an essential component of the outwardly rectifying chloride channels (ORCC) [43, 44] . Over-expressed ANO6, ANO8 and ANO10 possess a variable CaCC activity, but with a lower calcium sensitivity and magnitude than ANO1 [26, 42] . FRT [30, 45] , express ANO6, ANO8 and ANO10, but not ANO1 [26] . These cells have no detectable CaCC activity and have been used as host cells to study CaCC activity following heterologous expression of anoctamins [20, 26] . It is therefore highly unlikely that ANO6, ANO8 or ANO10 mediate CaCC activity in FRTL-5 cells. Since FRT cells are completely devoid of thyroidspecific protein expression and function [45] , the differential expression of ANO1 between FRT and FRTL-5 cells is consistent with a link between ANO1 expression and the functional status of thyroid cells. An important question is whether ANO1 acts directly as an iodide channel, or indirectly by modulating iodide fluxes through pendrin or other pathways. ClC-5 and CFTR have both been proposed to supply chloride as the counter-ion for pendrin-mediated chloride/iodide exchange [18, 19] . However, ATP was still able to stimulate iodide efflux from FRTL-5 cells in the absence of chloride suggesting independence of pendrin activity. Another contentious point concerns the the preferred direction of ANO1-mediated fluxes in vivo. ANO1 has a strong outward rectification, at least with respect to chloride currents [21, 22] . However, ANO1 rectification is regulated by Ca
2+
, and the channel could mediate anion secretion or absorption in epithelial cells, depending on the interplay of membrane potential, equilibrium potential, and intracellular Ca 2+ [46] . ANO1 rectification is also dependent on the permeant anion. Replacement of chloride with NO 3 -as the permeant anion reduces outward rectification, possibly reflecting the higher occupancy of the pore due to the lower hydration energy of NO 3 - [46] . The same may be true of iodide which, like NO 3 -, has a lower hydration energy and a higher relative permeability towards ANO1 than chloride. In thyroid cells, NIS maintains a large outward electrochemical gradient for iodide providing a strong driving force for iodide efflux.
The results of this study suggest that ANO1 may be a novel pathway for the delivery of iodide into the follicular lumen for incorporation into thyroglobulin. Further studies are needed to confirm this role using more physiological thyroid models and iodide concentrations. Iodide efflux through pendrin may be sufficient to maintain basal thyroid hormone synthesis, but the activation of ANO1 may provide an acute supply of iodide under conditions of thyroid stimulation by calcium mobilizing agents. Although ATP is a ubiquitous extracellular messenger that is secreted by many cell types, particularly during inflammation, the physiological stimuli for ANO1 activation in the thyroid gland in vivo remain to be determined. In addition to supplying iodide for thyroid hormone synthesis, ANO1 may also facilitate chloride fluxes, necessary for the coordinated regulation of colloid composition and follicle volume. The identification of ANO1 as a pathway of iodide transport opens up new lines of investigation regarding its regulation and function under pathophysiological conditions, and its potential as a pharmacological target for the treatment of thyroid disease.
